Reena kumari 

Entering new global markets can be particularly confusing for businesses. The market research that removes the risks of this process is a must-have and is not a luxury. New geographies present new challenges. Businesses are faced with looming shifts in the market that can originate from the introduction of new competitive technologies. To reduce the risk that market shifts will cause on their strategic plans, businesses conduct focused market research.

Specialized market research and strategic management consulting firms such as Roots Analysis provide intelligence for markets in the pharmaceutical, biotechnology, medical technology, advanced electronics, semiconductors, and specialty chemicals industries. Roots Analysis was founded in 2013 by Gaurav Chaudhary.

The research that Roots Analysis provides aims to provide clients with insights that are relevant and practical for the niche, complex, and fast-changing commercial sectors.

Roots Analysis has created a highly distinctive position in the market research industry by providing clients with three key services:

Though Roots Analysis holds expertise across several sectors, especially semiconductors and specialty materials, Roots Analysis is well recognized for its work in specialty pharmaceuticals and life sciences.

Generic market reports often fail in healthcare because of a lack of consideration to the complexities of the field. Roots Analysis bridges this gap by analyzing the finer segments of the sector. This includes Cell and Gene Therapy, Antibody Drug Conjugates and Contract Development and Manufacturing Organizations (CDMOs), and specialized drug delivery systems. This level focus helps clients make informed decisions regarding not only the high dollar calls but also the available manufacturing capacity, whether a particular technical capability exists, and where a particular company may have a proprietary interest.

Broad strokes can easily undermine a well thought-out strategic initiative. Roots Analysis offers differentiated services given its primary research is structured and complemented by validated industry discussions with not only executives, but also technical domain experts and operational managers.

The research on ‘Genotoxicity Testing Market’ presents a comprehensive evaluation of the current state of the industry and offers well-supported insights into its outlook through 2035. It reviews historical changes in the market size and provides a factual representation of how regional performance and industry trends have evolved. The report also offers a high-level understanding of key industry elements, including market dynamics, segmentation, and revenue estimation over the forecast timeline.

The forecast has been developed based on market behavior, existing product demand, and segment-wise performance. The study outlines operational considerations and challenges in the industry and presents a data-driven outlook for future growth without assigning qualitative assumptions. It explores the relationship between market performance and segment activity, supporting a clearer view of the global landscape.

A detailed breakdown of the market has been presented using standard segment classification. The market is segmented by distribution by Report Attribute: Details, Forecast Period: Till 2035, Market Size in 2035: $2.7 Billion, CAGR: 6.8%, Type of Assay, In vivo, In vitro, Non-GLP / Screening, Assay / Test Offered, Comet Assay, Micronucleus Assay, Chromosomal Aberration Test, Genetic Mutation Test and Others, End User Industry, Chemical Industry, Healthcare Industry, Agriculture Industry, Cosmetic Industry, Other Industries, Key Geographical Regions, North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, Key Companies Profiled, Aurigene Pharmaceutical Services, Charles River Laboratories, GLR Laboratories, LabCorp, LSIM Safety Institute Sai LifeSciences, Syngene, Customization Scope: 15% Free Customization Option (equivalent to 5 analysts working days), Excel Data Packs (Complimentary), Market Landscape Analysis, Benchmarking Analysis, Publication Analysis, Academic Grant Analysis, Partnerships and Collaborations Analysis, Patent Analysis, Market Forecast and Opportunity Analysis.

Key Geographies
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa

Regional assessment is an important part of this study, and it focuses on how each area contributes to the broader Genotoxicity Testing Market share. The study includes regional market data and summarizes projected revenue across all major territories. It does not assign speculative drivers to these differences but rather presents factual estimations of performance based on recent and historical data. The report also provides neutral commentary on structural elements that may influence regional variations in adoption, supply, or regulation.

source of information: https://www.rootsanalysis.com/reports/genotoxicity-testing-services-market.html

The report titled ‘AAV Vector Market’ delivers a structured overview of how the industry has progressed over the years, along with expectations for future movement till 2035. This report evaluates changes in the market size and highlights important developments within the industry. It offers clarity on regional patterns, key segments, and broader structural shifts without relying on speculative forecasting.

These projections are supported by current and historical performance metrics, highlighting regional and segment-level shifts across the global landscape. The study also outlines some of the major challenges and approaches being used across industry to adapt to evolving market conditions. The market forecast section provides a grounded view of potential movements over time, based on verified data and observed patterns.

This report includes a complete segmentation of the AAV Vector Market. The segmentation is based on Distribution by Historical Trend: Since 2023, Forecast Period: Till 2035, Market Size 2026: USD 3.7 Billion, Market Size 2035: USD 10.8 Billion, CAGR (Till 2035): 13%, Key Players Profiled, Astellas Pharma, Charles River Laboratories, Cytiva (Acquired by Danaher), Lonza, Novartis Gene Therapies, Sanofi, Thermo Fisher Scientific, WuXi AppTec, Segments Covered, Adeno-associated Viral Vector based Therapies Landscape, Adeno-associated Viral Vector Manufacturers Landscape, Adeno-associated Viral Vector Manufacturing Technology Landscape, Company Competitiveness Analysis, Technology Competitiveness Analysis, Clinical Trial Analysis, Partnerships and Collaborations: Adeno-Associated Viral Vector Manufacturers, Partnerships and Collaborations: Adeno-Associated Viral Vector Therapy Developers, Patent Analysis, Start-up Health Indexing, Outsourcing: Go or No-Go Framework, Market Forecast and Opportunity Analysis.

Key Geographies
North America, Europe, Asia-Pacific and Rest of the World

In addition to a high-level overview, the report also discusses market share shifts across these regions and the economic performance within each geography. It presents reliable estimates of projected revenue and market contribution, maintaining a neutral stance on causal relationships or future assumptions. Emphasis is placed on identifying key structural elements influencing AAV Vector MarketSize, Share & Growth Trend Analysis Report (2026 - 2035) growth across different regional and application-based divisions. [Origin of Information: https://www.rootsanalysis.com/reports/adeno-associated-viral-vector-market.html]

The research on ‘DNA and Gene Cloning Services Market’ presents a comprehensive evaluation of the current state of the industry and offers well-supported insights into its outlook through 2035. It reviews historical changes in the market size and provides a factual representation of how regional performance and industry trends have evolved. The report also offers a high-level understanding of key industry elements, including market dynamics, segmentation, and revenue estimation over the forecast timeline.

The forecast has been developed based on market behavior, existing product demand, and segment-wise performance. The study outlines operational considerations and challenges in the industry and presents a data-driven outlook for future growth without assigning qualitative assumptions. It explores the relationship between market performance and segment activity, supporting a clearer view of the global landscape.

A detailed breakdown of the market has been presented using standard segment classification. The market is segmented by distribution by Historical Trend: Since 2018, Forecast Period: Till 2035, Current Market Size: USD 3.57 Billion, Market Size in 2035: USD 14.55 Billion, CAGR: 16.9%, Type Of Service Offered, Gene Synthesis, Custom Cloning, Sub-cloning, Others, Type of Company Size, Small, Mid-size, Large, Type of Gene, Standard Gene, Complex Gene, Others, Type of End-User, Academic and R&D, Pharmaceutical and Biotechnology Companies, Others, Key Geographical Regions, North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, Key Companies Profiled in theDNA and Gene Cloning Services Market, Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene and Twist Bioscience, PowerPoint Presentation(Complimentary): Available, Customization Scope: 15% Free Customization, Excel Data Packs(Complimentary), Market Landscape Analysis for DNA and Gene Cloning Service, Benchmark Analysis, Patents Related to DNA and Gene Cloning Analysis, Key Insights Analysis, Competitive Landscape Analysis, Market Forecast, Partnerships and Collaborations Analysis, Funding and Investments Analysis.

Key Geographies
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa

Regional assessment is an important part of this study, and it focuses on how each area contributes to the broader DNA and Gene Cloning Services Market share. The study includes regional market data and summarizes projected revenue across all major territories. It does not assign speculative drivers to these differences but rather presents factual estimations of performance based on recent and historical data. The report also provides neutral commentary on structural elements that may influence regional variations in adoption, supply, or regulation.

Biopharmaceutical manufacturing is increasingly moving toward flexible production systems that can accommodate diverse products and changing demand. Single-use bioreactors have become an important part of this transition by replacing traditional stainless-steel vessels with disposable culture bags and associated components.
One of the major advantages of single-use systems is operational flexibility. Manufacturers can reduce cleaning and sterilization requirements while potentially lowering the risk of cross-contamination. These characteristics can be particularly valuable for facilities producing multiple biologics or operating at smaller and clinical scales.

According to Roots Analysis, the global single-use bioreactors market is expected to grow significantly as biopharmaceutical manufacturers adopt flexible and scalable production technologies. Pharmaceutical and biotechnology companies represent important end users as biologics pipelines continue to expand.
The technology is also relevant to the growing production of monoclonal antibodies, vaccines, recombinant proteins, gene therapies and cell therapies. As manufacturing pipelines become more diversified, the ability to rapidly configure production environments can provide significant operational advantages.

For pharmaceutical companies and CDMOs, the adoption of single-use bioreactors can support more flexible capacity planning and potentially shorten manufacturing turnaround times. Equipment providers are consequently developing increasingly sophisticated systems with improved monitoring, automation and process-control capabilities.
As demand for biologics continues to expand, single-use bioreactors are likely to remain an important technology within the broader movement toward flexible and scalable bioprocessing.

For more information on the single-use bioreactors market, visit:
https://www.rootsanalysis.com/reports/single-use-bioreactors-market.html

Overview of the Cold Plasma in Healthcare Market

Roots Analysis has published a report on the global Cold Plasma in Healthcare market, The global cold plasma in healthcare market size, valued at USD 2.57 billion in 2024, is projected to reach USD 2.98 billion in 2025 and USD 10.04 billion by 2035, representing a CAGR of 12.9% during the forecast period. This market research report delivers a detailed and up-to-date analysis of the industry, covering market size, share, growth trends, key drivers, restraints, opportunities, and competitive landscape. Designed for business leaders, investors, and analysts, the report provides actionable intelligence to support strategic planning, market entry decisions, and long-term investment strategies.

Key Findings of the Study:

Request for free sample, https://www.rootsanalysis.com/reports/cold-plasma-in-healthcare-market/request-sample.html

There are more key players involved in Cold Plasma in Healthcare market mentioned in the report

Cold Plasma in Healthcare Market Segmentation Insights

This report presents a detailed, data-driven analysis of the global Healthcare Cloud Computing Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global healthcare cloud computing market, valued at USD 62.92 billion in 2024, is projected to reach USD 74.24 billion in 2025 and USD 286.27 billion by 2035, representing a CAGR of 14.4% during the forecast period.

Roots Analysis recently published a report on the global Medical Carts Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Market Size and Forecast

Current Market Size:USD 3.48 Billion

Future Market Size: USD 12.85 Billion

CAGR: 13.9%

Market Overview

This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.

This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.

Reference: https://www.rootsanalysis.com/reports/medical-carts-market.html

Market Scope and Segmentation

- Historical Trend: Since 2020
- Forecast Period: Till 2035
- Current Market Size: USD 3.48 Billion
- Market Size 2035: USD 12.85 Billion
- CAGR till 2035: 13.9%
- Type of Product
                • Mobile Computing Carts (
                • Wall-Mounted WorkstationsMedication Carts
                • Medical Storage Columns
                • Cabinets & Accessories
                • Others
- Type of Medical Cart
                • Anesthesia Carts
                • Emergency Carts
                • Procedure Carts
                • Others
- Type of Material
                • Metal
                • Plastic
                • Wood
                • Combination
- Type of Mechanism
                • Manual
                • Electric
                • Hybrid
- Type of Payload
                • 50 Kg
                • 65 Kg
                • 80 Kg
                • 150 Kg
                • 180 Kg
                • Others
- Application Area
                • Medical Supply Storage
                • Surgical Tool Handling
                • Transporting and Dispensing Medicine
                • Laboratory
                • Other Application Areas
- Type of Distribution Channel
                • Direct Tenders
                • Third Party Distributors
                • Other Distribution Channels
- End User
                • Hospitals
                • Ambulatory Surgical Centers
                • Physician Offices / Clinics
                • Other End Users
- Geographical Regions
                • North America (
                • Europe (
                • Asia-Pacific (
                • Middle East and North Africa (
                • Latin America (
- Key Companies Profiled
                • Armstrong Medical Industries
                • Advantech
                • AFC Industries
                • Altus
                • Cura Carts
                • Capsa Solutions
                • Capsa Healthcare
                • Ergotron
                • Harloff Company
                • Jaco
                • Medline Industries
                • Midmark
                • Metro Healthcare Solutions
                • Parity Medical
                • Rubbermaid Healthcare
                • Stanley Black & Decker (
                • TouchPoint Medical
- PowerPoint Presentation(Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs(Complimentary): Available

Roots Analysis recently published a report on the global Metagenomic Sequencing Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Market Size and Forecast

Current Market Size:USD 2.55 Billion

Future Market Size: USD 8.64 Billion

CAGR: 13.0%

Market Overview

This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.

This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.

Reference: https://www.rootsanalysis.com/reports/metagenomic-sequencing-market.html

Market Scope and Segmentation

Type of Offering

Type of Workflow

Type of Technology

Application Area

End User

By Region

North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America

This report presents a detailed, data-driven analysis of the global Synthetic Biology Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global synthetic biology market is projected to grow from USD 23.88 billion in 2025 to USD 130.67 billion by 2035, representing a compounded annual growth rate of 18.53% during the forecast period.

Read More: https://www.rootsanalysis.com/reports/synthetic-biology-market.html

Market Segmentation

- Historical Trend: Since 2019
- Forecast Period: Till 2035
- Market Size 2035: USD 130.67 billion
- Market CAGR: ~18.53%
- Type of Product
                • Core Products
                • Enabling Products
                • Enabled Products
- Type of Tool
                • Oligonucleotides and Synthetic DNA
                • Enzymes
                • Cloning Technology Kits
                • Synthetic Cells
- Type of Technology
                • Gene Synthesis
                • Genome Engineering
                • Microfluidics
                • Nanotechnology
                • Sequencing
                • Bioinformatics
                • Site-Directed Mutagenesis
                • Cloning
                • Measurement and Modeling
                • Polymerase Chain Reaction
- Type of Application
                • Healthcare
                • Artificial Tissue & Tissue Regeneration
                • Industrial
                • Environmental
                • Food
                • Agriculture
- End User
                • Biotechnology and Pharmaceutical companies
                • Academic and Research Institutes
                • Other End Users
- Geographical Regions
                • North America
                • Europe
                • Asia Pacific
                • Middle East and North Africa
                • Latin America
- Key Companies Profiled
                • BASF
                • Codexis
                • Eurofins Scientific
                • GenScript
                • Illumina
                • Merck
                • Precigen
                • Thermo Fisher Scientific
                • Agilent Technologies
                • Bota Bio
                • Creative Biogene
                • Elevate Bio
                • Gingko Bioworks
                • New England Biolabs
                • Synbio Technologies
                • Synthego
                • Creative Enzymes.
                • Novozymes
                • Pareto Bio
                • Scarab Genomics
- PowerPoint Presentation(Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs(Complimentary): Available